OneMedNet Receives Mid Six-Figure Re-Order from Foundation Model Company

OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook

OneMedNet Corporation announced preliminary third-quarter 2026 revenue of approximately $1 million and provided revenue guidance for the fourth quarter of 2026.

OneMedNet Receives High Six-Figure Add-On Order Under Multiyear Agreement

OneMedNet Corporation has secured a high six-figure add-on order from a precision medicine customer, exercising an expansion option that increases data volume by 150%.

OneMedNet Enters Its 12th Channel Partner Agreement With A Global Pharmaceutical Intelligence And Data Solutions Provider To Distribute Its Clinical Data; Terms Not Disclosed

The agreement broadens OneMedNet’s reach into one of the fastest-growing segments of life sciences data. The global Real-World Data market is estimated at approximately US$2.7 billion in 2026 and is projected to reach

OneMedNet Announces Addition Of Hospital Systems To Its iRWD Platform, Intends To Expand Network By Up To 12 Additional Hospitals

OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven

OneMedNet Announces Initial One-Year Korea Distribution Agreement With Mediplexus For Its U.S. Healthcare Data; Terms Not Disclosed

OneMedNet shares are trading higher after the company announced a seven-figure multi-year agreement to deliver de-identified, multimodal, longitudinal clinical Real World Data to a commercially scaled AI-enabled precision medicine company.